Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 49 entries
Sorted by: Best Match Show Resources per page
[Formulation of a non-related anonymous screening program for HIV].

Medicina clinica

Estébanez P, Fitch K, Cifuentes I.
PMID: 7791412
Med Clin (Barc). 1995 May 20;104(19):753-6.

No abstract available.

Cite
Estébanez P, Fitch K, Cifuentes I. Formulación de un programa de cribado anónimo no relacionado para el VIH. [Formulation of a non-related anonymous screening program for HIV]. Med Clin (Barc). 1995;104(19):753-6
Estébanez, P., Fitch, K., & Cifuentes, I. (1995). Formulación de un programa de cribado anónimo no relacionado para el VIH. [Formulation of a non-related anonymous screening program for HIV]. Medicina clinica, 104(19), 753-6.
Estébanez, P, et al. "Formulación de un programa de cribado anónimo no relacionado para el VIH." [Formulation of a non-related anonymous screening program for HIV]. Medicina clinica vol. 104,19 (1995): 753-6.
Estébanez P, Fitch K, Cifuentes I. Formulación de un programa de cribado anónimo no relacionado para el VIH. [Formulation of a non-related anonymous screening program for HIV]. Med Clin (Barc). 1995 May 20;104(19):753-6. Spanish. PMID: 7791412.
Copy Download .nbib Format: NLM
Screening with discrimination.

BMJ (Clinical research ed.)

[No authors listed]
PMID: 2123412
BMJ. 1990 Nov 10;301(6760):1099-100.
Free PMC Article

No abstract available.

Cite
Screening with discrimination. BMJ. 1990;301(6760):1099-100
(1990). Screening with discrimination. BMJ (Clinical research ed.), 301(6760), 1099-100.
"Screening with discrimination." BMJ (Clinical research ed.) vol. 301,6760 (1990): 1099-100.
Screening with discrimination. BMJ. 1990 Nov 10;301(6760):1099-100. PMID: 2123412; PMCID: PMC1664243.
Copy Download .nbib Format: NLM
Screening for colorectal cancer.

Annals of internal medicine

[No authors listed]
PMID: 1984398
Ann Intern Med. 1991 Jan 15;114(2):166-7. doi: 10.7326/0003-4819-114-2-166.

No abstract available.

Cite
Screening for colorectal cancer. Ann Intern Med. 1991;114(2):166-7doi: 10.7326/0003-4819-114-2-166.
(1991). Screening for colorectal cancer. Annals of internal medicine, 114(2), 166-7. https://doi.org/10.7326/0003-4819-114-2-166
"Screening for colorectal cancer." Annals of internal medicine vol. 114,2 (1991): 166-7. doi: https://doi.org/10.7326/0003-4819-114-2-166
Screening for colorectal cancer. Ann Intern Med. 1991 Jan 15;114(2):166-7. doi: 10.7326/0003-4819-114-2-166. PMID: 1984398.
Copy Download .nbib Format: NLM
Author reply: To PMID 22928174.

Annals of internal medicine

Wallace EA, Schumann JH, Weinberger SE.
PMID: 23552298
Ann Intern Med. 2013 Mar 19;158(6):500. doi: 10.7326/0003-4819-158-6-201303190-00019.

No abstract available.

Cite
Wallace EA, Schumann JH, Weinberger SE. Author reply: To PMID 22928174. Ann Intern Med. 2013;158(6):500doi: 10.7326/0003-4819-158-6-201303190-00019.
Wallace, E. A., Schumann, J. H., & Weinberger, S. E. (2013). Author reply: To PMID 22928174. Annals of internal medicine, 158(6), 500. https://doi.org/10.7326/0003-4819-158-6-201303190-00019
Wallace, Erik A, et al. "Author reply: To PMID 22928174." Annals of internal medicine vol. 158,6 (2013): 500. doi: https://doi.org/10.7326/0003-4819-158-6-201303190-00019
Wallace EA, Schumann JH, Weinberger SE. Author reply: To PMID 22928174. Ann Intern Med. 2013 Mar 19;158(6):500. doi: 10.7326/0003-4819-158-6-201303190-00019. PMID: 23552298.
Copy Download .nbib Format: NLM
Costs and cost-effectiveness of colorectal cancer prevention and therapy.

Seminars in oncology

Schrag D, Weeks J.
PMID: 10528905
Semin Oncol. 1999 Oct;26(5):561-8.

For cancer, the evaluation of new prevention and therapeutic strategies has traditionally focused almost exclusively on safety and efficacy. However, comparison of the costs and cost-effectiveness of medical interventions is increasingly being recognized as an important goal. Cancer care...

Cite
Schrag D, Weeks J. Costs and cost-effectiveness of colorectal cancer prevention and therapy. Semin Oncol. 1999;26(5):561-8
Schrag, D., & Weeks, J. (1999). Costs and cost-effectiveness of colorectal cancer prevention and therapy. Seminars in oncology, 26(5), 561-8.
Schrag, D, and Weeks, J. "Costs and cost-effectiveness of colorectal cancer prevention and therapy." Seminars in oncology vol. 26,5 (1999): 561-8.
Schrag D, Weeks J. Costs and cost-effectiveness of colorectal cancer prevention and therapy. Semin Oncol. 1999 Oct;26(5):561-8. PMID: 10528905.
Copy Download .nbib Format: NLM
Average-risk screening: is public policy compatible with individual needs?.

Surgical oncology clinics of North America

Levin B, Hawley ST.
PMID: 11008231
Surg Oncol Clin N Am. 2000 Oct;9(4):665-77; discussion 679-81.

The issue of the appropriateness of population-based screening for colorectal cancer has been much debated in the literature. The purpose of screening is to find early-stage disease among average-risk members of the population so that timely treatment may be...

Cite
Levin B, Hawley ST. Average-risk screening: is public policy compatible with individual needs?. Surg Oncol Clin N Am. 2000;9(4):665-77; discussion 679-81
Levin, B., & Hawley, S. T. (2000). Average-risk screening: is public policy compatible with individual needs?. Surgical oncology clinics of North America, 9(4), 665-77; discussion 679-81.
Levin, B, and Hawley, S T. "Average-risk screening: is public policy compatible with individual needs?." Surgical oncology clinics of North America vol. 9,4 (2000): 665-77; discussion 679-81.
Levin B, Hawley ST. Average-risk screening: is public policy compatible with individual needs?. Surg Oncol Clin N Am. 2000 Oct;9(4):665-77; discussion 679-81. PMID: 11008231.
Copy Download .nbib Format: NLM
Screening strategies for early detection of lung cancer: the time is now.

JAMA

Petty TL.
PMID: 11035898
JAMA. 2000 Oct 18;284(15):1977-80. doi: 10.1001/jama.284.15.1977.

No abstract available.

Cite
Petty TL. Screening strategies for early detection of lung cancer: the time is now. JAMA. 2000;284(15):1977-80doi: 10.1001/jama.284.15.1977.
Petty, T. L. (2000). Screening strategies for early detection of lung cancer: the time is now. JAMA, 284(15), 1977-80. https://doi.org/10.1001/jama.284.15.1977
Petty, T L. "Screening strategies for early detection of lung cancer: the time is now." JAMA vol. 284,15 (2000): 1977-80. doi: https://doi.org/10.1001/jama.284.15.1977
Petty TL. Screening strategies for early detection of lung cancer: the time is now. JAMA. 2000 Oct 18;284(15):1977-80. doi: 10.1001/jama.284.15.1977. PMID: 11035898.
Copy Download .nbib Format: NLM
Cost-effectiveness of screening for HIV.

The New England journal of medicine

Thrasher AD, Ford CL, Nearing KA.
PMID: 15906435
N Engl J Med. 2005 May 19;352(20):2137-9; author reply 2137-9.

No abstract available.

Cite
Thrasher AD, Ford CL, Nearing KA. Cost-effectiveness of screening for HIV. N Engl J Med. 2005;352(20):2137-9; author reply 2137-9
Thrasher, A. D., Ford, C. L., & Nearing, K. A. (2005). Cost-effectiveness of screening for HIV. The New England journal of medicine, 352(20), 2137-9; author reply 2137-9.
Thrasher, Angela D, et al. "Cost-effectiveness of screening for HIV." The New England journal of medicine vol. 352,20 (2005): 2137-9; author reply 2137-9.
Thrasher AD, Ford CL, Nearing KA. Cost-effectiveness of screening for HIV. N Engl J Med. 2005 May 19;352(20):2137-9; author reply 2137-9. PMID: 15906435.
Copy Download .nbib Format: NLM
Taking dementia seriously.

BMJ (Clinical research ed.)

Gordon PJ.
PMID: 22514228
BMJ. 2012 Apr 18;344:e2745. doi: 10.1136/bmj.e2745.

No abstract available.

Cite
Gordon PJ. Taking dementia seriously. BMJ. 2012;344:e2745doi: 10.1136/bmj.e2745.
Gordon, P. J. (2012). Taking dementia seriously. BMJ (Clinical research ed.), 344e2745. https://doi.org/10.1136/bmj.e2745
Gordon, Peter J. "Taking dementia seriously." BMJ (Clinical research ed.) vol. 344 (2012): e2745. doi: https://doi.org/10.1136/bmj.e2745
Gordon PJ. Taking dementia seriously. BMJ. 2012 Apr 18;344:e2745. doi: 10.1136/bmj.e2745. PMID: 22514228.
Copy Download .nbib Format: NLM
Screening for diabetes.

Pathology

Backholer K, Chen L, Shaw J.
PMID: 22228253
Pathology. 2012 Feb;44(2):110-4. doi: 10.1097/PAT.0b013e32834e8e12.

The prevalence of type 2 diabetes is rapidly increasing. A strong rationale exists for identifying asymptomatic individuals who are at high risk or are likely to have diabetes. Screening programs may provide a conduit through which diabetes intervention may...

Cite
Backholer K, Chen L, Shaw J. Screening for diabetes. Pathology. 2012;44(2):110-4doi: 10.1097/PAT.0b013e32834e8e12.
Backholer, K., Chen, L., & Shaw, J. (2012). Screening for diabetes. Pathology, 44(2), 110-4. https://doi.org/10.1097/PAT.0b013e32834e8e12
Backholer, K, et al. "Screening for diabetes." Pathology vol. 44,2 (2012): 110-4. doi: https://doi.org/10.1097/PAT.0b013e32834e8e12
Backholer K, Chen L, Shaw J. Screening for diabetes. Pathology. 2012 Feb;44(2):110-4. doi: 10.1097/PAT.0b013e32834e8e12. PMID: 22228253.
Copy Download .nbib Format: NLM
Cost-effectiveness of primary screening for CKD: a systematic review.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Komenda P, Ferguson TW, Macdonald K, Rigatto C, Koolage C, Sood MM, Tangri N.
PMID: 24529536
Am J Kidney Dis. 2014 May;63(5):789-97. doi: 10.1053/j.ajkd.2013.12.012. Epub 2014 Feb 12.

BACKGROUND: Chronic kidney disease (CKD) is a major health problem with an increasing incidence worldwide. Data on the cost-effectiveness of CKD screening in the general population have been conflicting.STUDY DESIGN: Systematic review.SETTING & POPULATION: General, hypertensive, and diabetic populations....

Cite
Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014;63(5):789-97doi: 10.1053/j.ajkd.2013.12.012.
Komenda, P., Ferguson, T. W., Macdonald, K., Rigatto, C., Koolage, C., Sood, M. M., & Tangri, N. (2014). Cost-effectiveness of primary screening for CKD: a systematic review. American journal of kidney diseases : the official journal of the National Kidney Foundation, 63(5), 789-97. https://doi.org/10.1053/j.ajkd.2013.12.012
Komenda, Paul, et al. "Cost-effectiveness of primary screening for CKD: a systematic review." American journal of kidney diseases : the official journal of the National Kidney Foundation vol. 63,5 (2014): 789-97. doi: https://doi.org/10.1053/j.ajkd.2013.12.012
Komenda P, Ferguson TW, Macdonald K, Rigatto C, Koolage C, Sood MM, Tangri N. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014 May;63(5):789-97. doi: 10.1053/j.ajkd.2013.12.012. Epub 2014 Feb 12. PMID: 24529536.
Copy Download .nbib Format: NLM
The impact of a co-payment on the cost-effectiveness of screening for diabetic retinopathy.

Journal of public health (Oxford, England)

Lian J, McGhee SM, Gangwani RA, Chan CK, Lam CL, Yap MK, Wong DS.
PMID: 28158645
J Public Health (Oxf). 2016 Dec 02;38(4):782-792. doi: 10.1093/pubmed/fdv168.

No abstract available.

Cite
Lian J, McGhee SM, Gangwani RA, et al. The impact of a co-payment on the cost-effectiveness of screening for diabetic retinopathy. J Public Health (Oxf). 2016;38(4):782-792doi: 10.1093/pubmed/fdv168.
Lian, J., McGhee, S. M., Gangwani, R. A., Chan, C. K., Lam, C. L., Yap, M. K., & Wong, D. S. (2016). The impact of a co-payment on the cost-effectiveness of screening for diabetic retinopathy. Journal of public health (Oxford, England), 38(4), 782-792. https://doi.org/10.1093/pubmed/fdv168
Lian, JinXiao, et al. "The impact of a co-payment on the cost-effectiveness of screening for diabetic retinopathy." Journal of public health (Oxford, England) vol. 38,4 (2016): 782-792. doi: https://doi.org/10.1093/pubmed/fdv168
Lian J, McGhee SM, Gangwani RA, Chan CK, Lam CL, Yap MK, Wong DS. The impact of a co-payment on the cost-effectiveness of screening for diabetic retinopathy. J Public Health (Oxf). 2016 Dec 02;38(4):782-792. doi: 10.1093/pubmed/fdv168. PMID: 28158645.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 49 entries